CommercialPrior AuthLow impact
Nuplazid (pimavanserin)
Blue Cross & Blue Shield of Mississippi·MS · Neurology, Psychiatry, Family Medicine +1 more·Medical Policy
We identified it
Jun 20, 2026
Summary
BCBS Mississippi updated their Nuplazid (pimavanserin) policy removing the requirement that patients cannot be treated with additional antipsychotics, and clarifying that sample medications don't count as stable therapy for prior authorization approval. The policy still requires prior authorization and trial/failure of clozapine or quetiapine before approval.
Action Required
Immediately: Review any pending or denied Nuplazid prior authorization requests to determine if patients previously denied due to concurrent antipsychotic use may now qualify for approval. Update prior authorization checklists to reflect that sample medication use does not satisfy treatment requirements. Billing team should verify patient formulary coverage before submitting claims.